logo
Share SHARE
FONT-SIZE Plus   Neg

CytomX Therapeutics Holding On To Strong Gain In Late-Day Trading

Shares of CytomX Therapeutics (CTMX) have pulled back off their highs of the session but continue to significant strength in late-day trading on Wednesday. After reaching its best intraday level in well over a year, CytomX is currently up by 20.5 percent.

The jump by CytomX comes after the biopharmaceutical company announced it has entered into a strategic collaboration with Amgen (AMGN) in immuno-oncology.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
While Democrats have largely been critical of the Republican tax reform plan, President Donald Trump has claimed the proposal has some bipartisan support. Trump suggested to reporters ahead of a meeting with members of the Senate Finance Committee on Wednesday that "people on both sides" support the tax reform plan. Healthcare is very expensive in the U.S., in fact among the most expensive in the world by most measures. Health care facilities are largely owned and operated by businesses in the private sector. Most Americans have access to health care, though costs and services vary from state to state. However,... Electronic Arts Inc. said it is shutting down its Visceral Games Studio and making major changes to its upcoming Star Wars project currently being developed by the studio. Visceral Games is best known for creating the "Dead Space" series.
comments powered by Disqus
Follow RTT